Abstract:Objective To Observe dynamically the level of CD_4~+ CD_(25)~+ Tregs in the peripheral blood in patients with liver failure receiving artificial liver support system and/or medical treatment and investigate the relationship between the level of CD_4~+ CD_(25)~+ Tregs and curative effect and prognosis.Methods Sixty-three patients with liver failure were divided into 2 groups according to the treatment protocol:medical treatment combined with artificial liver support system(combined group)(29 cases)and medical treatment only group (medical group)(34 cases).According to indicators such as liver function and clinical symptoms etc,there were 17 effective cases and 12 ineffective cases in the combined group while 11 effective cases and 23 ineffective cases in the medical group.23 healthy donors were used as normal control group.The level of CD_4~+ CD_(25)~+ Treg in the peripheral blood was measured by flow cytometry dynamically and the relationship between the level of CD_4~+ CD_(25)~+ Treg and curative effect was analyzed accordingly.Results The Treg level was(2.46±0.56)% in the normal control group.For those effective groups,the Treg level before treatment was lower compared to normal control group,it was(1.92±0.78)% and(2.10±0.56)% in combined group and medical group respectively.There was no significant difference between these two groups (P0.05)although it was statistically significant when both compared to the normal control group(P 0.05);After treatment,the Treg level in the effective groups was(2.62±0.67)%(combined group)and (2.89±0.72)%(medical group)respectively.There was significant difference between these two groups (P0.05)while no statistical significant was found when compared to the normal control group(P 0.05);Both effective groups showed significant difference before and after the treatment(P0.05);As to the ineffective groups,the Treg level was higher before treatment compared to the normal control.It was (4.64±1.31)%(combined group)and(4.87±2.86)%(medical group)respectively.There was no significant difference between these two groups(P0.05)while it was statistical significant when compared to the normal control group(P0.05);After treatment the Treg level in the ineffective groups was(5.44± 2.13)%(combined group)and(5.91±2.78)%(medical group)respectively.There was no significant difference between these two groups(P0.05)although it was statistically significant compared to the normal control group(P0.05).There was significant difference before and after the treatment in both ineffective groups(P0.05).The change of Treg level appeared to show low-high-low peaked curve in the effective groups and it recovered to the normal level soon in the combined group compared to the medical treatment group.In the ineffective treatment groups,the change of Treg level appeared to be high-low-high notched curve.Conclusion The level of CD_4~+ CD_(25)~+ Treg was correlated with the curative effect and it may be used as a potential indicator for curative effect and prognosis in patients with liver failure.

Changes of Plasma Cytokines in Patients with Severe Hepatitis Treated with a Probiotic Preparation

Expressions of IL-18,IL-12 and IFN-γ in Chronic Severe Hepatitis Patients and Treatment with Artificial Liver Support System

Changes in Intestinal Microflora in Patients with Chronic Severe Hepatitis

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

[Study on the Intestinal Microbial Colonization Resistance in Patients with Chronic Severe Hepatitis].

Altered Faecal Microbiota on the Expression of Th Cells Responses in the Exacerbation of Patients with Hepatitis E Infection.

Level Changes and Clinical Significance of Plasma IL-18,IP-10 in Patients with Chronic Hepatitis B During Antiviral Treatment

Effect of Probiotics on Immune Function of Patients with Cirrhosis

Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease

Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease.

Effect of Probiotic Treatment on Cirrhotic Patients with Minimal Hepatic Encephalopathy: A Meta-Analysis.

Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis.

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Modulation of Gut Microbiota by Probiotics to Improve the Efficacy of Immunotherapy in Hepatocellular Carcinoma

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Probiotic Yogurt Effects on Intestinal Flora of Patients with Chronic Liver Disease

Effect of Probiotic Yogurt in Long-Term Adjuvant Treatment of Patients with Liver Cirrhosis after Hepatitis B

Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.

An Investigation on Relationship Between the Level of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood and Curative Effect in Patients with Liver Failure

Gut microbiota dysbiosis associated with plasma levels of Interferon-gamma and viral load in patients with acute hepatitis E infection